Thai State Council Takes Up Compulsory Licensing Issue
This article was originally published in PharmAsia News
Executive Summary
Thailand's Council of State has taken up the issue of the whether the Public Health Ministry's policy of imposing compulsory licensing on foreign drug makers is legal. Sanofi Aventis of France, seeking to protect the patent on its Taxotere (doxetaxel) breast cancer drug, earlier petitioned the government to review the ministry's CL policy, which the company said violates two articles of the nation's Patent Act. The Commerce Ministry, given authority over such issues by the act, sought a ruling by the Council of State. The AIDS Access Foundation has urged the council to keep the CL policy in place. (Click here for more
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.